{"url_path":"/sec/syre/8-k/2026-06-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1636282/0001636282-26-000083-index.html","accession_number":"0001636282-26-000083","cik":"0001636282","ticker":"SYRE","issuer_name":"Spyre Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1636282/0001636282-26-000083-index.html","primary_entity_key":"0001636282","primary_entity_name":"Spyre Therapeutics, Inc."},"word_count":82,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d)Exhibits\n\nExhibit Number\nDescription\n\n99.1\n[Press release issued by Spyre Therapeutics, Inc. regarding Data, dated June 15, 2026.](exhibit99120260615skyline-.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n  \nSPYRE THERAPEUTICS, INC.\n\n   \n\nDate:\nJune 15, 2026\nBy: /s/ Cameron Turtle\n\n   Cameron Turtle\nChief Executive Officer"}